Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Rasagiline Mesylate.
| Product ID | 67877-259_56dcb533-2d6b-430b-9b01-ab4aacd4589a |
| NDC | 67877-259 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rasagiline |
| Generic Name | Rasagiline |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-10-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA201889 |
| Labeler Name | Ascend Laboratories, LLC |
| Substance Name | RASAGILINE MESYLATE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-10-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA201889 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-10-30 |
| Ingredient | Strength |
|---|---|
| RASAGILINE MESYLATE | .5 mg/1 |
| SPL SET ID: | 5dfeec8f-f4f3-4e06-915e-3244467516a6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-3060 | Rasagiline | Rasagiline |
| 0093-3061 | Rasagiline | Rasagiline |
| 16714-770 | Rasagiline | Rasagiline |
| 16714-771 | Rasagiline | Rasagiline |
| 42291-779 | Rasagiline | Rasagiline |
| 42291-780 | Rasagiline | Rasagiline |
| 42571-220 | RASAGILINE | Rasagiline |
| 42571-221 | RASAGILINE | Rasagiline |
| 47781-683 | Rasagiline | Rasagiline |
| 47781-690 | Rasagiline | Rasagiline |
| 67877-259 | Rasagiline | Rasagiline |
| 67877-260 | Rasagiline | Rasagiline |